These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 38018862

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial.
    de Boniface J, Appelgren M, Szulkin R, Alkner S, Andersson Y, Bergkvist L, Frisell J, Gentilini OD, Kontos M, Kühn T, Lundstedt D, Offersen BV, Olofsson Bagge R, Reimer T, Sund M, Christiansen P, Rydén L, Filtenborg Tvedskov T, SENOMAC Trialists’ Group.
    Lancet Oncol; 2024 Sep; 25(9):1222-1230. PubMed ID: 39121881
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?
    Farley C, Bassett R, Meric-Bernstam F, Bedrosian I, Caudle A, DeSnyder S, Hunt K, Kuerer H, Singh P, Sun S, Tamirisa N, Teshome M, Hwang RF.
    Ann Surg Oncol; 2023 Dec; 30(13):8327-8334. PubMed ID: 37670121
    [Abstract] [Full Text] [Related]

  • 7. Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer with One to Three Positive Sentinel Lymph Nodes.
    Kantor O, Weiss A, Burstein HJ, Mittendorf EA, King TA.
    Ann Surg Oncol; 2022 Nov; 29(12):7674-7682. PubMed ID: 35763229
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk Factors for Non-sentinel Lymph Node Metastasis in HR+/HER2- Breast Cancer With cN0.
    Na YM, Park SC, Ryu YJ, Cho JS, Park MH.
    Anticancer Res; 2024 Aug; 44(8):3493-3500. PubMed ID: 39060066
    [Abstract] [Full Text] [Related]

  • 10. Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib.
    Gaillard T, Piketty J, Feron JG, Girard N, Pauly L, Gauroy E, Darrigues L, Grandal B, Pierga JY, Hamy-Petit AS, Reyal F, Laas E.
    Br J Cancer; 2024 Apr; 130(7):1141-1148. PubMed ID: 38280968
    [Abstract] [Full Text] [Related]

  • 11. Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
    Zhang W, Xu J, Wang K, Tang XJ, Liang H, He JJ.
    BMC Womens Health; 2020 Jul 09; 20(1):143. PubMed ID: 32646416
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Individualized prediction of non-sentinel lymph node metastasis in Chinese breast cancer patients with ≥ 3 positive sentinel lymph nodes based on machine-learning algorithms.
    Xie X, Fang Y, He L, Chen Z, Chen C, Zeng H, Chen B, Huang G, Guo C, Zhang Q, Wu J.
    BMC Cancer; 2024 Sep 02; 24(1):1090. PubMed ID: 39223574
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
    Davis J, Boughey JC, Hoskin TL, Day CN, Cheville JC, Piltin MA, Hieken TJ.
    Clin Breast Cancer; 2021 Oct 02; 21(5):458-465. PubMed ID: 33839043
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
    Mamtani A, Patil S, Van Zee KJ, Cody HS, Pilewskie M, Barrio AV, Heerdt AS, Morrow M.
    Ann Surg Oncol; 2016 Oct 02; 23(11):3481-3486. PubMed ID: 27169771
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes.
    Aragon-Sanchez S, Oliver-Perez MR, Madariaga A, Tabuenca MJ, Martinez M, Galindo A, Arroyo ML, Gallego M, Blanco M, Ciruelos-Gil EM.
    Breast J; 2022 Oct 02; 2022():1507881. PubMed ID: 36051467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.